Nuvalent (NUVL) Non-Current Assets (2021 - 2026)
Nuvalent (NUVL) posted Non-Current Assets of $23.2 million for Q1 2026, up 14.46% on a QoQ basis from $20.3 million in Q4 2025, and up 20.56% year-over-year from $19.3 million in Q1 2025.
Nuvalent (NUVL) Non-Current Assets (2021 - 2026) Analysis & Trends
Nuvalent's Non-Current Assets history runs 6 years deep, the most recent figure standing at $23.2 million for Q1 2026.
- Quarterly Non-Current Assets rose 20.56% year-over-year to $23.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $87.4 million (up 87.08% YoY) and the FY2025 annual result came in at $20.3 million, up 117.96% from the prior year.
- Non-Current Assets was $23.2 million for Q1 2026 at Nuvalent, up from $20.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $23.2 million in Q1 2026 and bottomed at $2.6 million in Q1 2022.
- A 5-year average of $10.6 million and a median of $9.0 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets fell 0.52% — and 2025, when it soared 150.08%.
- Nuvalent's Non-Current Assets stood at $4.5 million in 2022, then soared by 31.96% to $5.9 million in 2023, then jumped by 57.8% to $9.3 million in 2024, then jumped by 117.96% to $20.3 million in 2025, then rose by 14.46% to $23.2 million in 2026.
- Business Quant data shows NUVL's Non-Current Assets at $23.2 million in Q1 2026, $20.3 million in Q4 2025, and $23.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 23.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.21 Mn |
| Dec 31, 2025 | 20.28 Mn |
| Sep 30, 2025 | 22.97 Mn |
| Jun 30, 2025 | 20.93 Mn |
| Mar 31, 2025 | 19.25 Mn |
| Dec 31, 2024 | 9.30 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Jun 30, 2024 | 8.97 Mn |
| Mar 31, 2024 | 8.97 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 5.31 Mn |
| Jun 30, 2023 | 4.96 Mn |
| Mar 31, 2023 | 4.70 Mn |
| Dec 31, 2022 | 4.47 Mn |
| Sep 30, 2022 | 4.31 Mn |
| Jun 30, 2022 | 4.20 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 3.20 Mn |
| Sep 30, 2021 | 2.83 Mn |
| Jun 30, 2021 | 4.22 Mn |